APA (7th ed.) Citation

Tauziède-Espariat, A., Uro-Coste, E., Nicaise, Y., Sievers, P., von Deimling, A., Sahm, F., . . . Varlet, P. (2023). Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status. Acta Neuropathologica Communications, 11(1), 1. https://doi.org/10.1186/s40478-023-01667-x

Chicago Style (17th ed.) Citation

Tauziède-Espariat, Arnault, et al. "Refinement of Diagnostic Criteria for Pediatric-type Diffuse High-grade Glioma, IDH- and H3-wildtype, MYCN-subtype Including Histopathology, TP53, MYCN and ID2 Status." Acta Neuropathologica Communications 11, no. 1 (2023): 1. https://doi.org/10.1186/s40478-023-01667-x.

MLA (9th ed.) Citation

Tauziède-Espariat, Arnault, et al. "Refinement of Diagnostic Criteria for Pediatric-type Diffuse High-grade Glioma, IDH- and H3-wildtype, MYCN-subtype Including Histopathology, TP53, MYCN and ID2 Status." Acta Neuropathologica Communications, vol. 11, no. 1, 2023, p. 1, https://doi.org/10.1186/s40478-023-01667-x.